Clinical Trial Update: Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography

View source ↗

Summary

Completed clinical trial evaluating dopamine receptor function in healthy controls and patients with schizophrenia and schizoaffective disorder using PET radiol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Fallypride (Fallypride)
• NNC-112 (NNC-112)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Schizoaffective Disorder, Schizophrenia | Status: COMPLETED